Skip to main content

Displaying 121 - 132 of 569

Co-CEO Kelleher Reports a Large RILY Buy

December 20, 2023

From the Desk of Steve Strazza and Alfonso Depablos

The only transaction on today’s list comes in a Form 4 filing by Tom Kelleher, co-CEO of B. Riley Financial $RILY.

Kelleher reported a purchase of $404,392.

This is the 14th Form 4 filed for RILY this year.

Baker Bros Reports a $30 Million MDGL Buy

December 15, 2023

From the Desk of Steve Strazza and Alfonso Depablos

The most significant transaction on today’s list comes in a Form 4 filing by Baker Bros Advisors LP.

The hedge fund reported a purchase of $30 million in Madrigal Pharmaceuticals Inc $MDGL.

Buffett's Into OXY for Another $588 Million

December 14, 2023

From the Desk of Steve Strazza and Alfonso Depablos

The most significant transaction on today’s list comes in a Form 4 filing by Warren Buffett and Berkshire Hathaway.

Buffett reported another substantial purchase in Occidental Petroleum Corp $OXY, this time with a total value of $588 million.

Cormorant Reports a $10 Million EYPT Buy

December 13, 2023

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Cormorant Asset Management LP.

The investment firm reported the acquisition of 588,235 shares of EyePoint Pharmaceuticals Inc $EYPT, equivalent to roughly $10 million.

Top EV Exec Buys 182,000 F Shares

December 12, 2023

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Doug Field, chief EV, digital and design officer of Ford Motor Company $F.

Field reported a purchase of 182,000 F shares, equivalent to $2 million.

Insiders Are Buying HTLD, BSM, OLMA, and FIX

December 11, 2023

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Julie J. Durr, the co-trustee of the Ann S. Gerdin Revocable Trust, which owns 10 percent of Heartland Express $HTLD.

Durr reported the acquisition of 182,268 HTLD shares, equivalent to $2,501,143.

Cormorant Reports a $42 Million EYPT Purchase

December 7, 2023

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Cormorant Asset Management.

The investment firm reported a purchase of $41,874,150 in EyePoint Pharmaceuticals $EYPT.